B. anthracis edema toxin increases cAMP levels and inhibits phenylephrinestimulated contraction in a rat aortic ring model

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 2, 2013, Pages

  Li, Yan ^a   Cui, Xizhong ^a   Solomon, Steven B ^a   Remy, Kenneth ^a   Fitz, Yvonne ^a   Eichacker, Peter Q ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anthrax; Aortic ring model; Arterial contraction; Edema toxin; Lethal toxin

Indexed keywords

ADEFOVIR; ADENYLATE CYCLASE; ANTHRAX TOXIN; BACTERIAL TOXIN; CYCLIC AMP; EDEMA FACTOR; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; AORTA; AORTA CONSTRICTION; ARTERY DILATATION; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; HEART MUSCLE CONTRACTILE FORCE; LETHAL GENE; MALE; MICROBIAL VIABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANTHRAX; AORTIC RING MODEL; ARTERIAL CONTRACTION; EDEMA TOXIN; LETHAL TOXIN;

ADENINE; ANIMALS; ANTIGENS, BACTERIAL; AORTA; BACTERIAL TOXINS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ORGANOPHOSPHONATES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84880171842     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00185.2013     Document Type: Article

References (45)

1. 2+ sensitivity in vascular smooth muscle cells. J Anesth 21: 232-242, 2007.
2. Auguet M, Delaflotte S, Pirotzky E, Clostre F, Braquet P. Role of endothelium on phenylephrine-triggered contractile events in aorta of spontaneously hypertensive rats. Fundam Clin Pharmacol 3: 655-664, 1989.
3. Barochia AV, Cui X, Sun J, Li Y, Solomon SB, Migone TS, Subramanian GM, Bolmer SD, Eichacker PQ. Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines. J Infect Dis 205: 818-829, 2012.
4. Booth MG, Hood J, Brooks TJ, Hart A. Anthrax infection in drug users. Lancet 375: 1345-1346, 2010.
5. Callera GE, Yeh E, Tostes RC, Caperuto LC, Carvalho CR, Bendhack LM. Changes in the vascular β-adrenoceptor-activated signalling pathway in 2kidney-1clip hypertensive rats. Br J Pharmacol 141: 1151-1158, 2004.
6. Cui X, Li Y, Li X, Laird MW, Subramanian M, Moayeri M, Leppla SH, Fitz Y, Su J, Sherer K, Eichacker PQ. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis 195: 572-580, 2007.
7. Cui X, Moayeri M, Li Y, Li X, Haley M, Fitz Y, Correa-Araujo R, Banks SM, Leppla SH, Eichacker PQ. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol 286: R699-R709, 2004.
8. Cui X, Su J, Li Y, Shiloach J, Solomon S, Kaufman JB, Mani H, Fitz Y, Weng J, Altaweel L, Besch V, Eichacker PQ. Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model. Intensive Care Med 36: 148-156, 2010.
9. Ebrahimi CM, Sheen TR, Renken CW, Gottlieb RA, Doran KS. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect Immun 79: 2510-2518, 2011.
10. Firoved AM, Miller GF, Moayeri M, Kakkar R, Shen Y, Wiggins JF, McNally EM, Tang WJ, Leppla SH. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 167: 1309-1320, 2005.
11. Golden HB, Watson LE, Lal H, Verma SK, Foster DM, Kuo SR, Sharma A, Frankel A, Dostal DE. Anthrax toxin: pathologic effects on the cardiovascular system. Front Biosci 14: 2335-2357, 2009.
12. Gottle M, Dove S, Kees F, Schlossmann J, Geduhn J, Konig B, Shen Y, Tang WJ, Kaever V, Seifert R. Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry 49: 5494-5503, 2010.
13. Gozes Y, Moayeri M, Wiggins JF, Leppla SH. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun 74: 1266-1272, 2006.
14. Guichard A, Nizet V, Bier E. New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect 14: 97-118, 2012.
15. Hicks CW, Cui X, Sweeney DA, Li Y, Barochia A, Eichacker PQ. The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock. Toxins (Basel) 3: 1185-1202, 2011.
16. Hicks CW, Li Y, Okugawa S, Solomon SB, Moayeri M, Leppla SH, Mohanty A, Subramanian GM, Mignone TS, Fitz Y, Cui X, Eichacker PQ. Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model. Am J Physiol Heart Circ Physiol 300: H1108-H1118, 2011.
17. Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med 38: 1092-1104, 2012.
18. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7: 933-944, 2001.
19. Kirby JE. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 72: 430-439, 2004.
20. Leppla S. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79: 6, 1982.
21. Leysath CE, Chen KH, Moayeri M, Crown D, Fattah R, Chen Z, Das SR, Purcell RH, Leppla SH. Mouse monoclonal antibodies to anthrax edema factor protect against infection. Infect Immun 79: 4609-4616, 2011.
22. Maddugoda MP, Stefani C, Gonzalez-Rodriguez D, Saarikangas J, Torrino S, Janel S, Munro P, Doye A, Prodon F, Aurrand-Lions M, Goossens PL, Lafont F, Bassereau P, Lappalainen P, Brochard F, Lemichez E. cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization. Cell Host Microbe 10: 464-474, 2011.
23. Metrich M, Berthouze M, Morel E, Crozatier B, Gomez AM, Lezoualc'h F. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology. Pflügers Arch 459: 535-546, 2010.
24. Migone TS, Subramanian GM, Zhong J, Healey LM, Corey A, Devalaraja M, Lo L, Ullrich S, Zimmerman J, Chen A, Lewis M, Meister G, Gillum K, Sanford D, Mott J, Bolmer SD. Raxibacumab for the treatment of inhalational anthrax. N Engl J Med 361: 135-144, 2009.
25. Moayeri M, Crown D, Dorward DW, Gardner D, Ward JM, Li Y, Cui X, Eichacker P, Leppla SH. The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS). PLoS Pathog 5: e1000456, 2009.
26. Moayeri M, Haines D, Young HA, Leppla SH. Bacillus anthracis lethal toxin induces TNF--independent hypoxia-mediated toxicity in mice. J Clin Invest 112: 670-682, 2003.
27. Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 30: 439-455, 2009.
28. Moayeri M, Sastalla I, Leppla SH. Anthrax and the inflammasome. Microbes Infect 14: 392-400, 2012.
29. Morgado M, Cairrao E, Santos-Silva AJ, Verde I. Cyclic nucleotidedependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69: 247-266, 2012.
30. Nakaki T, Otsuka Y, Kato R. Tension-induced release of endotheliumderived relaxing factor; possible role in establishment of desensitization of norepinephrine-induced contraction in rat aorta. Jpn J Pharmacol 54: 491-494, 1990.
31. Pezard C, Berche P, Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59: 3472-3477, 1991.
32. Qiu P, Li Y, Shiloach J, Cui X, Sun J, Trinh sc L-B, Kubler-Kielb J, Vinogradov E, Mani H, Al-Hamad M, Fitz Y, Eichacker PQ. B. anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model. J Infect Dis. June 3, 2013. doi:10.1093/infdis/jit247.
33. Rascado RR, Bendhack LM. Activation of 2-adrenoceptors is necessary to induce nitric oxide release in isoprenaline-induced relaxation. Vascul Pharmacol 42: 63-68, 2005.
34. Remy KE, Cui X, Solomon SB, Sun J, Migone TS, Bolmer SD, Al-Hamad M, Li Y, Fitz Y, Eichacker PQ. Hemodynamic support and early treatment with protective antigen directed monoclonal antibody together improve survival in a canine model of anthrax edema toxin induced shock (Abstract). The International Conference of American Thoracic Society, Philadelphia, PA, May 17-22, 2013.
35. Sayner SL. Emerging themes of cAMP regulation of the pulmonary endothelial barrier. Am J Physiol Lung Cell Mol Physiol 300: L667-L678, 2011.
36. Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, Tang WJ. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci USA 101: 3242-3247, 2004.
37. Sherer K, Li Y, Cui X, Li X, Subramanian M, Laird MW, Moayeri M, Leppla SH, Fitz Y, Su J, Eichacker PQ. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med 35: 1560-1567, 2007.
38. Stanley JL, Smith H. Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol 26: 49-63, 1961.
39. Sweeney DA, Cui X, Solomon SB, Vitberg DA, Migone TS, Scher D, Danner RL, Natanson C, Subramanian GM, Eichacker PQ. Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J Infect Dis 202: 1885-1896, 2010.
40. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. Am J Respir Crit Care Med 184: 1333-1341, 2011.
41. Tessier J, Green C, Padgett D, Zhao W, Schwartz L, Hughes M, Hewlett E. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect Immun 75: 1895-1903, 2007.
42. Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA, Boyer AE, Guarner J, Wilkins P, Norville KJ, Barr JR, Zaki SR, Patel JB, Reagan SP, Pirkle JL, Treadwell TA, Messonnier NR, Rotz LD, Meyer RF, Stephens DS. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis 44: 968-971, 2007.
43. Warfel JM, Steele AD, D'Agnillo F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 166: 1871-1881, 2005.
44. Watson LE, Kuo SR, Katki K, Dang T, Park SK, Dostal DE, Tang WJ, Leppla SH, Frankel AE. Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLos One 2: e466, 2007.
45. Watson LE, Mock J, Lal H, Lu G, Bourdeau RW, Tang WJ, Leppla SH, Dostal DE, Frankel AE. Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front Biosci 12: 4670-4675, 2007.